Artwork

Indhold leveret af AUAUniversity and American Urological Association. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af AUAUniversity and American Urological Association eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Advances in ADT Part II: A Guide for Urologists

44:09
 
Del
 

Manage episode 378729909 series 2497848
Indhold leveret af AUAUniversity and American Urological Association. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af AUAUniversity and American Urological Association eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Advances in ADT Part II: A Guide for Urologists CME Available: https://auau.auanet.org/node/39385 Release Date: October, 2023 Expiration Date: October, 2024 LEARNING OBJECTIVES After participating in this educational activity, participants will be able to: 1. Recognize and characterize different disease states for advance prostate cancer including M0 HSPC, M1 HSPC, M0 CRPC, and M1 CRPC. 2. Discuss the role of a multidisciplinary shared team approach for the diagnosis and management of advanced prostate cancer. 3. Facilitate discussions with patients and caregivers regarding treatment intensification for advanced prostate cancer. 4. Identify the role of combination therapy with ADT and additional systemic therapy to yield optimal survival outcomes for metastatic prostate cancer. 5. Differentiate mechanisms of action and side effects when ADT is delivered via GnRH agonists vs. antagonists. ACKNOWLEDGEMENTS Independent educational grant support provided by: Myovant Sciences LTD Pfizer, Inc.
  continue reading

339 episoder

Artwork
iconDel
 
Manage episode 378729909 series 2497848
Indhold leveret af AUAUniversity and American Urological Association. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af AUAUniversity and American Urological Association eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Advances in ADT Part II: A Guide for Urologists CME Available: https://auau.auanet.org/node/39385 Release Date: October, 2023 Expiration Date: October, 2024 LEARNING OBJECTIVES After participating in this educational activity, participants will be able to: 1. Recognize and characterize different disease states for advance prostate cancer including M0 HSPC, M1 HSPC, M0 CRPC, and M1 CRPC. 2. Discuss the role of a multidisciplinary shared team approach for the diagnosis and management of advanced prostate cancer. 3. Facilitate discussions with patients and caregivers regarding treatment intensification for advanced prostate cancer. 4. Identify the role of combination therapy with ADT and additional systemic therapy to yield optimal survival outcomes for metastatic prostate cancer. 5. Differentiate mechanisms of action and side effects when ADT is delivered via GnRH agonists vs. antagonists. ACKNOWLEDGEMENTS Independent educational grant support provided by: Myovant Sciences LTD Pfizer, Inc.
  continue reading

339 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning